Biosimilars - A New Innovation Pathway to Affordable Medicine

Event description
Changing regulations and a looming biotech patent cliff have created enormous opportunity in the global market for biosimilars to boom over the next few years. Are they generics or copycat drugs? No, but they are expected to slash the cost of some of our most widely used drugs by nearly half. Join us to find out how biosimilars could revolutionize the concept of cost-effective healthcare, and the regulatory and commercial challenges posed by this innovation pathway.

The panel represents diverse perspectives from the life sciences ecosystem and will discuss the following key topics: how biosimilars differ from generic products, FDA regulations and the cost of developing a biosimilar, and the implications for pharma, physicians, and patients.

Our esteemed panelists include: Susan Dexter, principal consultant, Latham Biopharm, Magdalena Leszcyniecka, president and CEO, STC Biologics, Inc; Michael Wyand, chief technology officer, EPIRUS Biopharmaceuticals and moderator, Marie Sanchirico, medical managed care director, Genzyme, A Sanofi Company.

Learning objectives
1. Define biosimilars and why they are considered a new innovation pathway
2. Identify the main challenges surrounding biosimilars from a clinical, regulatory and commercial standpoint
3. Identify the implications for key stakeholders by the introduction of biosimilars into the marketplace

Agenda
5:30 PM - 6:30 PM   Registration and networking
6:30 PM - 7:45 PM   Panel discussion, Q&A
7:45 PM - 8:30 PM   Networking and additional discussion time

Event location
Genzyme, A Sanofi Company, Roscoe Brady Auditorium
500 Kendall Street
Cambridge, MA, 02142
617 252 7500

Directions

Special instructions:
Parking is in public garage close to building. Accessible from the Kendall T station.

Sponsors

Speakers
Susan Dexter
Principal consultant, Latham Biopharma

Magdalena Leszczyniecka
President and CEO, STC Biologics

Marie Sanchirico
Medical managed care director, Genzyme, a Sanofi Company

Michael Wyand
Chief technical officer, EPIRUS Biopharmaceuticals

Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: June 9, 2015
Onsite (walk-in) registration: Is allowed

Capacity
Is capacity limited? Yes
Space is limited to 100 registrants.

Cancellations/refunds
Is this event refundable? Yes
If yes, requests must be submitted in writing to events@hbanet.org by June 3, 2015; no refunds are available after this date.

Event questions/support
- Chapter contact for event: Sudipta Mahajan at sudipta_mahajan@vrtx.com or
508-254-0579
- Membership questions: membership@hbanet.org or 973-575-0606 ext 1
- Online registration assistance: events@hbanet.org or 973-575-0606 ext 3

Visit us online

Pricing

	Member	Non-Member
Regular Registration	$20.00 / €17.00	$40.00 / €34.00

Members receive up to 50 percent discount

Event Policies

Photography Policy
By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.

COVID-19 Policy
The HBA requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.

By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any HBA volunteers participating in the activity will act individually and will not represent the HBA. As a condition to my participation the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.

Special Needs Policy
The HBA will make reasonable modifications to policies and programs to ensure that people with special needs can enjoy all of its programs. Contact us if you require special accommodations for this event.